Comparison of Safety and Effectiveness Between Direct Oral Anticoagulants and Vitamin K Antagonists in Dementia Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Systematic review comparing DOACs and VKAs found DOACs reduced certain bleeding risks in dementia patients, suggesting tailored anticoagulant strategies.
Key Points
DOACs significantly reduced intracranial hemorrhage compared to VKAs in dementia patients with AF.
The meta-analysis included eight studies with up to 40,350 participants, highlighting the extensive data pool.
OAC use lowered mortality risk by 29% compared to no anticoagulation, though major bleeding risks increased.
The findings underline the importance of careful selection of anticoagulants for the vulnerable population of dementia patients.